Endothelial nitric oxide synthase gene polymorphisms and the risk of vasculopathy in sickle cell disease

Hematology

Volumn 21, Issue 6, 2016, Pages 359-367

  Yousry, Sherif M ^a   Ellithy, Hend N ^a   Shahin, Gehan H ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Gene polymorphisms; Nitric oxide synthase; Sickle cell disease; Vasculopathy

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DNA EXTRACTION; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; THORAX RADIOGRAPHY; VASCULAR DISEASE; YOUNG ADULT; ADOLESCENT; COMPLICATION; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84978539111     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245332.2016.1142710     Document Type: Article

References (31)

1. D.J.Weatherall. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010;115:4331–6. doi: 10.1182/blood-2010-01-251348
2. H.F.Bunn. Sickle hemoglobin and other hemoglobin mutants. In: G.Stamatoyannopoulos, A.W.Nienhuis, P.W.Majerus, H.Varmus, (eds.) The molecular basis of blood diseases. Philadelphia: WB Saunders; 1994. p. 207–56.
3. G.R.Serjeant, B.E.Serjeant, J.S.Mohan, A.Clare. Leg ulceration in sickle cell disease: medieval medicine in a modern world. Hematol Oncol Clin North Am. 2005;19:943–56. doi: 10.1016/j.hoc.2005.08.005
4. G.R.Serjeant. Sickle cell disease. 2nd ed. Oxford: Oxford University Press; 1992.
5. K.C.Wood, L.L.Hsu, M.T.Gladwin. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biol Med. 2008;44:1506–28. doi: 10.1016/j.freeradbiomed.2008.01.008
6. G.J.Kato, S.Martyr, W.C.Blackwelder, J.S.Nichols, W.A.Coles, L.A.Hunter, Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol. 2005;130(6):943–53. doi: 10.1111/j.1365-2141.2005.05701.x
7. M.T.Gladwin, V.Sachdev, M.L.Jison, Y.Shizukuda, J.F.Plehn, K.Minter, Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886–95. doi: 10.1056/NEJMoa035477
8. H.F.Bunn, D.G.Nathan, G.J.Dover, R.P.Hebbel, O.S.Platt, W.F.Rosse, Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 2010;116(5):687–92. doi: 10.1182/blood-2010-02-268193
9. W.C.Sessa. eNOS at a glance. J Cell Sci. 2004;117:2427–9. doi: 10.1242/jcs.01165
10. K.A.PritchardJr., J.Ou, Z.Ou, Y.Shi, J.P.Franciosi, P.Signorino, Hypoxia-induced acute lung injury in murine models of sickle cell disease. Am J Physiol Lung Cell Mol Physiol. 2004;286:705L–14. doi: 10.1152/ajplung.00288.2002
11. C.R.Morris, F.A.Kuypers, S.Larkin, E.Vichinsky, L.Styles. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol. 2000;22:515–20. doi: 10.1097/00043426-200011000-00009
12. T.Tsukada, K.Yokoyama, T.Aria, F.Takemoto, S.Hara, A.Yamada, Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophysics Res Commun. 1998;245:190–3. doi: 10.1006/bbrc.1998.8267
13. T.A.Kunnas, E.Ilveskoski, T.Niskakangas, P.Laippala, O.A.Kajander, J.Mikkelsson, Association of the endothelial nitric oxide synthase gene polymorphism with risk of coronary artery disease and myocardial infarction in middle-aged men. J Mol Med. 2002;80:605–9. doi: 10.1007/s00109-002-0365-z
14. X.L.Wang, J.Wang. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab. 2000;70:241–51. doi: 10.1006/mgme.2000.3033
15. S.Nagase, H.Suzuki, Y.Wang, S.Kikuchi, A.Hirayama, A.Ueda, Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem. 2003;244(1–2):113–8. PMID: 12701818 doi: 10.1023/A:1022473405275
16. M.Endres, U.Laufs, J.K.Liao, M.A.Moskowitz. Targeting eNOS for stroke protection. Trends Neurosci. 2004;27:283–9. doi: 10.1016/j.tins.2004.03.009
17. V.Tarer, M.Etienne-Julan, J.P.Diara, M.S.Belloy, M.Mukizi-Mukaza, J.Elion, Sickle cell anemia in Guadeloupean children: pattern and prevalence of acute clinical events. Eur J Haematol. 2006;76:193–9. doi: 10.1111/j.1600-0609.2005.00590.x
18. S.K.Ballas, S.Lieff, L.J.Benjamin, Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85:6–13. doi: 10.1002/ajh.21750
19. S.J.Ambrusko, S.Gunawardena, A.Sakara, B.Windsor, L.Lanford, P.Michelson, Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr Blood Cancer. 2006;47(7):907–13. doi: 10.1002/pbc.20791
20. A.Guash, M.Cua, W.E.Mitch. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int. 1996;49:686–91.
21. S.S.Nishank, M.P.Singh, R.Yadav, R.B.Gupta, V.S.Gadge, A.Gwal. Endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease patients in India. J Hum Genet. 2013;58:775–9. doi: 10.1038/jhg.2013.99
22. M.Tesauro, W.C.Thompson, P.Rogliani, L.Qi, P.P.Chaudhary, J.Moss. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with tartrate vs. glutamate at position 298. Proc Natl Acad Sci USA. 2000;97:2832–5. doi: 10.1073/pnas.97.6.2832
23. R.Liu, P.Geng, M.Ma, S.Yu, X.Wang, W.Zhang, Association between endothelial nitric oxide synthase gene polymorphism (T-786C) and ischemic stroke susceptibility: a meta-analysis. Int J Neurosci. 2014;124(9):642–51. doi: 10.3109/00207454.2013.873978
24. A.Ekmekçi, K.S.Ozcan, B.Güngör, N.Abaci, D.Osmonov, A.Zencirci, The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary artery disease. Acta Cardiol. 2013;68:464–8.
25. A.A.Tantawy, A.A.Adly, E.A.Ismail, S.H.Aly. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in sickle cell disease: relation to vasculopathy and disease severity. Pediatr Blood Cancer. 2015;62(3):389–94. doi: 10.1002/pbc.25234
26. T.J.Thakur, A.Guindo, L.R.Cullifer, Y.Li, I.G.Imumorin, D.A.Diallo, Endothelin-1 but not endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease in Africa. Gene Regul Syst Biol. 2014;8:119–26. doi:10.4137/GRSB.S14836
27. A.E.Vargas, M.A.L.da Silva, L.Silla, J.A.B.Chies. Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease. Tissue Antigens. 2005;66:683–90. doi: 10.1111/j.1399-0039.2005.00506.x
28. K.Sharan, S.Surrey, S.Ballas, M.Borowski, M.Devoto, K.F.Wang, Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Hematol. 2004;124:240–3. doi: 10.1046/j.1365-2141.2003.04762.x
29. V.Chaar, V.Tarer, M.Etienne-Julan, J.P.Diara, J.Elion, M.Romana. ET-1 and ecNOS gene polymorphisms and susceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia. Haematologica. 2006;91(9):1277–8.
30. A.K.Mack, G.J.Kato. Sickle cell disease and nitric oxide: a paradigm shift? Int J Biochem Cell Biol. 2006;38:1237–43. doi: 10.1016/j.biocel.2006.01.010
31. M.F.Elshamaa, S.Sabry, A.Badr, M.El-Ahmady, E.A.Elghoroury, E.H.Thabet, Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in patients with chronic kidney disease. Blood Coagul Fibrinolysis. 2011;22:487–92. doi: 10.1097/MBC.0b013e328346ef71